Market revenue in 2022 | USD 181.8 million |
Market revenue in 2030 | USD 297.1 million |
Growth rate | 6.3% (CAGR from 2022 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Clinical |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical, Pre-clinical |
Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.43% in 2022. Horizon Databook has segmented the UAE lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The U.A.E. is one of the most developed among the GCC countries. Its pharmaceutical and healthcare industry is one of the major contributors to its economic growth. According to the World Bank, the overall spending on healthcare and pharmaceuticals is estimated to be 4.6% of the total country’s GDP by 2026.
In addition, it was reported that the growth of the UAE pharmaceutical industry is anticipated to be positive in the long run. Moreover, the U.A.E.'s healthcare industry is expanding due to demographic changes in its population.
According to the World Bank, the proportion of people over 65 years in the United Arab Emirates will rise from 1.1% to 4.4% by 2030. This will increase the demand for healthcare, especially geriatric care. The lipid market is poised to grow on account of the overall growth of the pharmaceutical industry in the U.A.E.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE lipid market , including forecasts for subscribers. This country databook contains high-level insights into UAE lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account